Sanofi Pasteur, the vaccines division of Sanofi, has said that it is launching ShanIPV, an injectable inactivated polio vaccine (IPV) in the country.
"The first doses of IPV ShanIPV will be soon available for infants in the country. This new polio vaccine is manufactured by Shantha Biotechnics in Hyderabad. These first vaccine doses will be available to implement one dose of IPV in India's immunisation schedule for all infants," Sanofi Pasteur said in a statement here.
Sanofi Pasteur provides over one billion doses of vaccine each year. Over 20 million newborns will eventually benefit from this new vaccine every year, the release said.
"With the introduction of IPV in their immunisation schedule, India moves the world much closer to being polio-free", Sanofi Pasteur President and CEO Olivier Charmeil said.
"As a company deeply rooted in India, we are very proud that vaccines produced by both Sanofi Pasteur and Shantha will be used in this vital step towards a polio-free world," Charmeil said.
